filgrastim-sndz

CHEBI:CHEBI_750710

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
1605075
product_type
HUMAN PRESCRIPTION DRUG
listing_expiration_date
20251231
dosage_form
INJECTION, SOLUTION
route
INTRAVENOUS
package_marketing_start_date
20180222
marketing_category
BLA
active_ingredient_name
FILGRASTIM
active_ingredient_strength
300 ug/.5mL
unii
PVI5M0M1GW
nui
N0000175666
pharm_class_epc
Leukocyte Growth Factor [EPC]
pharm_class
Granulocyte Colony-Stimulating Factor [CS]
pharm_class_pe
Increased Myeloid Cell Production [PE]
pharm_class_cs
Granulocyte Colony-Stimulating Factor [CS]
labeler_name
Sandoz Inc.
manufacturer_name
Sandoz Inc.
marketing_start_date
20150306
generic_name
filgrastim-sndz
brand_name
ZARXIO
brand_name_base
ZARXIO
product_ndc
61314-326
application_number
BLA125553
spl_id
6bab0064-3410-4701-97c8-b3e1465c6717
package_ndc
61314-326-10
package_description
2 BLISTER PACK in 1 CARTON (61314-326-10) / 5 SYRINGE in 1 BLISTER PACK (61314-326-05) / .8 mL in 1 SYRINGE
spl_set_id
c0d1c22b-566b-4776-bdbf-00f96dad0cae
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class